4//SEC Filing
Swift Christopher 4
Accession 0001225208-25-004786
CIK 0000874766other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:19 PM ET
Size
23.8 KB
Accession
0001225208-25-004786
Insider Transaction Report
Form 4
Swift Christopher
Executive VP and CFO
Transactions
- Exercise/Conversion
Stock Option
2025-05-02−96,816→ 98,160 totalExercise: $43.59Exp: 2026-03-01→ Common Stock (96,816 underlying) - Exercise/Conversion
Common Stock
2025-05-02$43.59/sh+96,816$4,220,209→ 307,897.948 total - Sale
Common Stock
2025-05-02$125.50/sh−96,816$12,150,379→ 211,081.948 total
Holdings
- 95,386(indirect: By Trust)
Common Stock
- 284,819
Stock Option
Exercise: $53.81Exp: 2028-02-27→ Common Stock (284,819 underlying) - 301,932
Stock Option
Exercise: $69.41Exp: 2032-02-23→ Common Stock (301,932 underlying) - 327,679
Stock Option
Exercise: $55.27Exp: 2030-02-25→ Common Stock (327,679 underlying) - 40,003(indirect: By Spouse)
Common Stock
- 99,403
Stock Option
Exercise: $116.41Exp: 2035-02-25→ Common Stock (99,403 underlying) - 116,414
Stock Option
Exercise: $95.74Exp: 2034-02-27→ Common Stock (116,414 underlying) - 60,865(indirect: By Trust)
Common Stock
- 352,263
Stock Option
Exercise: $49.01Exp: 2029-02-26→ Common Stock (352,263 underlying) - 310,820
Stock Option
Exercise: $51.87Exp: 2031-02-23→ Common Stock (310,820 underlying) - 302,908
Stock Option
Exercise: $48.89Exp: 2027-02-28→ Common Stock (302,908 underlying) - 248,933
Stock Option
Exercise: $78.28Exp: 2033-02-28→ Common Stock (248,933 underlying)
Footnotes (12)
- [F1]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 4, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2016 and are scheduled to expire on March 1, 2026.
- [F10]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
- [F11]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- [F12]One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- [F2]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $125.00 - $125.94 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
- [F4]The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
- [F5]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- [F6]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
- [F7]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- [F8]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
- [F9]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
Documents
Issuer
HARTFORD INSURANCE GROUP, INC.
CIK 0000874766
Entity typeother
Related Parties
1- filerCIK 0001349356
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:19 PM ET
- Size
- 23.8 KB